Healthequity — 2019 Investments

1 investments dated 2019 · listed companies and verified rows first · show all

Versantisversantis.com inSep 2019acquired by GENFIT

GENFIT is a biopharmaceutical company developing therapies for rare, life-threatening liver diseases, with a focus on acute-on-chronic liver failure (ACLF), hepatic encephalopathy (HE), cholangiocarcinoma, urea cycle disorders, and organic acidemias.

BiotechDigital HealthMedical Devices

Co-investorsOCCIDENT Verve Ventures Esperante Ventures redalpine

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.